Stockscreener 앱 받기
31.82
1.73%
0.54
시간 외 거래:
31.82
Ultragenyx Pharmaceutical Inc 주식(RARE)의 최신 뉴스
Real time scanner hits for Ultragenyx Pharmaceutical Inc. explained2025 Top Gainers & Consistent Profit Alerts - Newser
Ultragenyx Pharmaceutical Inc. stock daily chart insightsShort Setup & Daily Risk Controlled Trade Plans - Newser
Institutional scanner results for Ultragenyx Pharmaceutical Inc.Market Sentiment Report & Entry Point Confirmation Alerts - Newser
How to use Fibonacci retracement on Ultragenyx Pharmaceutical Inc.Weekly Trend Report & Fast Gain Stock Tips - Newser
Live market analysis of Ultragenyx Pharmaceutical Inc.Portfolio Risk Report & Fast Exit Strategy with Risk Control - Newser
What machine learning models say about Ultragenyx Pharmaceutical Inc.July 2025 Market Mood & Verified Technical Trade Signals - Newser
What earnings revisions data tells us about Ultragenyx Pharmaceutical Inc.2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Is Ultragenyx Pharmaceutical Inc. stock a good pick for beginnersGap Up & Long-Term Growth Plans - خودرو بانک
Ultragenyx Pharmaceutical Inc. recovery potential after sell offWeekly Investment Report & Safe Entry Point Identification - Newser
Applying sector rotation models to Ultragenyx Pharmaceutical Inc.July 2025 Selloffs & Safe Capital Growth Tips - Newser
Real time pattern detection on Ultragenyx Pharmaceutical Inc. stock2025 Investor Takeaways & Risk Managed Trade Strategies - Newser
Rare Disease Therapy Approvals By FDA Speed Up Via New ProcessNeurogene (NASDAQ:NGNE) - Benzinga
Ultragenyx’s Strategic Momentum: A Rare Disease Biotech on the Cusp of Multiple Catalysts - AInvest
Ultragenyx's Strategic Momentum in Rare Disease Innovation and Commercialization - AInvest
Transcript : Ultragenyx Pharmaceutical Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 10 - MarketScreener
Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y - MSN
News impact scoring models applied to Ultragenyx Pharmaceutical Inc.Weekly Risk Report & Entry Point Confirmation Signals - Newser
Long term hold vs stop loss in Ultragenyx Pharmaceutical Inc.Global Markets & Low Risk High Reward Trade Ideas - Newser
What does recent volatility data suggest for Ultragenyx Pharmaceutical Inc.2025 Key Lessons & High Accuracy Investment Signals - Newser
A | Is Ultragenyx Pharmaceutical Inc. stock good for income investorsJuly 2025 Review & Stepwise Trade Signal Guides - خودرو بانک
Reversal indicators forming on Ultragenyx Pharmaceutical Inc. stockGap Up & Weekly Return Optimization Plans - Newser
How to build a dashboard for Ultragenyx Pharmaceutical Inc. stockTrade Volume Report & Risk Controlled Daily Trade Plans - Newser
Order flow analysis tools used on Ultragenyx Pharmaceutical Inc.July 2025 Gainers & Consistent Growth Equity Picks - Newser
Intraday pattern recognizer results for Ultragenyx Pharmaceutical Inc.Quarterly Profit Review & Community Consensus Trade Signals - Newser
Ultragenyx Pharmaceutical shares rise 1.43% after-hours following a class action investigation announcement. - AInvest
What indicators show strength in Ultragenyx Pharmaceutical Inc.2025 Institutional Moves & Detailed Earnings Play Strategies - Newser
Does Ultragenyx Pharmaceutical Inc. offer margin of safetyTreasury Yields & Real-Time Volume Analysis Alerts - خودرو بانک
Trend analysis for Ultragenyx Pharmaceutical Inc. this weekQuarterly Profit Summary & Low Drawdown Trading Techniques - Newser
How to interpret RSI for Ultragenyx Pharmaceutical Inc. stockMarket Performance Report & Long-Term Capital Growth Strategies - Newser
How hedge fund analytics apply to Ultragenyx Pharmaceutical Inc. stockShort Setup & Weekly Chart Analysis and Guides - Newser
Will earnings trigger a reversal in Ultragenyx Pharmaceutical Inc.Portfolio Value Summary & Weekly Watchlist of Top Performers - Newser
Top chart patterns to watch in Ultragenyx Pharmaceutical Inc.2025 Support & Resistance & Verified Chart Pattern Trade Signals - Newser
Quantitative breakdown of Ultragenyx Pharmaceutical Inc. recent moveCEO Change & Entry Point Confirmation Signals - Newser
Ultragenyx Pharmaceutical Inc. stock trend forecastInsider Buying & Weekly Watchlist for Consistent Profits - Newser
Is Ultragenyx Pharmaceutical Inc. stock good for income investorsJuly 2025 Rallies & Weekly Market Pulse Alerts - خودرو بانک
Can Ultragenyx Pharmaceutical Inc. ride the EV waveTrade Exit Summary & AI Optimized Trading Strategy Guides - خودرو بانک
What’s the outlook for Ultragenyx Pharmaceutical Inc.’s sectorPortfolio Growth Summary & Weekly Market Pulse Updates - خودرو بانک
Published on: 2025-09-02 13:45:06 - Newser
Pomerantz LLP Investigates Claims Against Ultragenyx Pharmaceutical Inc. - AInvest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - FinancialContent
Full technical analysis of Ultragenyx Pharmaceutical Inc. stockWeekly Stock Summary & AI Forecast Swing Trade Picks - Newser
Is Ultragenyx Pharmaceutical Inc. being accumulated by smart moneyCPI Data & Weekly High Momentum Picks - خودرو بانک
1.40%
자본화:
|
볼륨(24시간):